Skip to content
Y 21 PILL

Y 21 PILL – IDENTIFICATION, MECHANISM OF ACTION, SIDE EFFECTS

The white, rectangular pill debossed with “Y” on one segment and “2 1” (or “21”) on another is Alprazolam 2 mg, manufactured by Aurobindo Pharma USA. Commonly known by street and clinical names as a generic “Xanax bar” or “white ladder,” it is a high-potency, immediate-release benzodiazepine. In the United States, it is classified as a Schedule IV (C-IV) controlled substance due to its high potential for physical dependence, misuse, and diversion.

Y 20 BLUE PILL

Y 20 BLUE PILL – IDENTIFICATION, MECHANISM OF ACTION, SIDE EFFECTS

The oval/football-shaped blue pill debossed with “Y” on one side and “2 0” (or “20”) on the reverse is Alprazolam 1 mg, manufactured by Aurobindo Pharma USA. It is a generic formulation of Xanax and belongs to the benzodiazepine drug class. In the United States, it is classified as a Schedule IV (C-IV) controlled substance due to its potential for misuse, dependence, and addiction.

UL 15 PILL

UL 15 PILL – IDENTIFICATION, MECHANISM OF ACTION, SIDE EFFECTS

The yellow/pale yellow oblong pill debossed with “U L” on one side and “15” on the other is Meloxicam 15 mg, manufactured by Unichem Pharmaceuticals (USA) Inc. It is a generic formulation of the prescription drug Mobic, belonging to the nonsteroidal anti-inflammatory drug (NSAID) class and primarily used to treat inflammatory joint conditions.

U27 BLUE PILL

U27 BLUE PILL – IDENTIFICATION, MECHANISM OF ACTION, SIDE EFFECTS

The round, blue (or light blue) pill debossed with “U27” is Dextroamphetamine-Amphetamine 10 mg (mixed amphetamine salts), manufactured by Aurobindo Pharma / Aurolife Pharma. It is a generic immediate-release formulation of Adderall 10 mg. Classified as a Schedule II (C-II) controlled substance in the United States, it carries a high potential for abuse, dependence, and diversion.

TL 706 PILL

TL 706 PILL – IDENTIFICATION,MECHANISM OF ACTION, SIDE EFFECTS

The round, yellow pill debossed with “TL 706” in black ink is Methylphenidate Hydrochloride Extended-Release (18 mg), manufactured by Trigen Laboratories (also distributed under brand equivalents such as Relexxii). It is a central nervous system (CNS) stimulant primarily prescribed to manage Attention Deficit Hyperactivity Disorder (ADHD) and is classified as a Schedule II (C-II) controlled substance in the United States due to a high risk of abuse, dependence, and diversion.